Oxidative damage of neurons is one of the key pathological markers of Alzheimer’s disease (AD), which eventually leads to neuronal apoptosis and loss. Nuclear factor E2-related factor 2 (Nrf2) is a key regulator of antioxidant response and is considered to be an important therapeutic target for neurodegenerative diseases. In this study, the selenated derivative of antioxidant rutin (Se-Rutin) was synthesized with sodium selenate (Na2SeO3) as raw material by a simple electrostatic-compound in situ selenium reduction method. The effects of Se-Rutin on H2O2 induced oxidative damage in Pheochromocytoma PC12 cells were evaluated by cell viability, apoptosis, reactive oxygen species level and the expression of antioxidant response element (Nrf2). The results showed that H2O2 treatment significantly increased the level of apoptosis and reactive oxygen species, while the level of Nrf2 and HO-1 decreased. However, Se-Rutin significantly reduced H2O2 induced apoptosis and cytotoxicity, and increased the expression of Nrf2 and HO-1, both of which were better than that of pure rutin. Therefore, the activation of Nrf2/HO-1 signaling pathway may be the basis of Se-Rutin’s anti-oxidative damage to AD.
ElmalehDRFarlowMRContiPS, et al.Developing effective Alzheimer’s disease therapies: clinical experience and future directions. J Alzheimers Dis2019; 71(3): 715–732.
5.
CummingsJLeeGNahedP, et al.Alzheimer’s disease drug development pipeline: 2022. Alzheimers Dement (NY)2022; 8(1): e12295.
6.
BloomGS. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol2014; 71(4): 505–508.
7.
LiYZhangJWanJ, et al.Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: a potential therapeutic molecule for Alzheimer’s disease. Biomed Pharmacother2020; 132: 110887.
8.
ChoiYKYuJSJohY, et al.Presence of endogenous Aβ in plasma of patient with Alzheimer’s disease differentiates Aβ oligomerization tendencies caused by synthetic Aβ. Alzheimer’s Dement2021; 17(Suppl.5): e053516.
9.
OsamaAZhangJYaoJ, et al.Nrf2: a dark horse in Alzheimer’s disease treatment. Ageing Res Rev2020; 64: 101206.
10.
KaundalRKDatusaliaAKSharmaSS. Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer’s disease. Pharmacol Res2022; 175: 106018.
11.
ZhangLGuoYWangH, et al.Edaravone reduces Aβ-induced oxidative damage in SH-SY5Y cells by activating the Nrf2/ARE signaling pathway. Life Sci2019; 221: 259–266.
12.
GuoXHuLWangZ, et al.Effect of rutin on the physicochemical and gel characteristics of myofibrillar protein under oxidative stress. J Food Biochem2021; 45(10): e13928.
13.
NegahdariRBohlouliSSharifiS, et al.Therapeutic benefits of rutin and its nanoformulations. Phytother Res2021; 35(4): 1719–1738.
14.
GaneshpurkarASalujaAK. The Pharmacological potential of rutin. Saudi Pharm J2017; 25(2): 149–164.
15.
PanRYMaJKongXX, et al.Sodium rutin ameliorates Alzheimer’s disease-like pathology by enhancing microglial amyloid-beta clearance. Sci Adv2019; 5(2): eaau6328.
16.
HabtemariamS. Rutin as a natural therapy for Alzheimer’s disease: insights into its mechanisms of action. Curr Med Chem2016; 23(9): 860–873.
17.
LiuYZhaoXZhangQ, et al.Characterization and evaluation of the solubility and oral bioavailability of rutin-ethanolate solvate. AAPS PharmSciTech2020; 21(7): 241.
HariharanSDharmarajS. Selenium and selenoproteins: it’s role in regulation of inflammation. Inflammopharmacology2020; 28(3): 667–695.
20.
SunWZhuJLiS, et al.Selenium supplementation protects against oxidative stress-induced cardiomyocyte cell cycle arrest through activation of PI3K/AKT. Metallomics2020; 12(12): 1965–1978.
21.
NiuRYangQDongY, et al.Selenium metabolism and regulation of immune cells in immune-associated diseases. J Cell Physiol2022; 237(9): 3449–3464.
22.
RazaghiAPoorebrahimMSarhanD, et al.Selenium stimulates the antitumour immunity: insights to future research. Eur J Cancer2021; 155: 256–267.
23.
KoraćBBuzadžićBBuzadžićB. Selenium supplementation and GSH-Px activity in the IBAT and erythrocytes of cold-adapted rats. Food Res Int2002; 35(2-3): 221–224.
24.
MonsenE R. Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids. J Am Diet Assoc2000; 100(6): 637–640.
25.
HeYChenSLiuZ, et al.Toxicity of selenium nanoparticles in male Sprague–Dawley rats at supranutritional and nonlethal levels. Life Sci2014; 115(1-2): 44–51.
26.
FerroCFlorindoHFSantosHA. Selenium nanoparticles for biomedical applications: from development and characterization to therapeutics. Adv Healthc Mater2021; 10(16): e2100598.
27.
ZamboninoMCQuizhpeEMJaramilloFE, et al.Green synthesis of selenium and tellurium nanoparticles: current trends, biological properties and biomedical applications. Int J Mol Sci2021; 22(3): 989.
28.
PrasadKSVaghasiyaJVSoniSS, et al.Microbial selenium nanoparticles (SeNPs) and their application as a sensitive hydrogen peroxide biosensor. Appl Biochem Biotechnol2015; 177(6): 1386–1393.
29.
KhuranaATekulaSSaifiMA, et al.Therapeutic applications of selenium nanoparticles. Biomed Pharmacother2019; 111: 802–812.
30.
GaoSLiTGuoY, et al.Selenium-containing nanoparticles combine the NK cells mediated immunotherapy with radiotherapy and chemotherapy. Adv Mater2020; 32(12): e1907568.
31.
AmaniHHabibeyRShokriF, et al.Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling. Sci Rep2019; 9(1): 6044.
32.
HanHWPatelKDKwakJH, et al.Selenium nanoparticles as candidates for antibacterial substitutes and supplements against multidrug-resistant bacteria. Biomolecules2021; 11(7): 1028.
33.
LeeSCLeeNHPatelKD, et al.The effect of selenium nanoparticles on the osteogenic differentiation of MC3T3-E1 cells. Nanomaterials (Basel)2021; 11(2): 557.
34.
AlbrakatiAAlsharifKFAl OmairiNE, et al.Neuroprotective efficiency of prodigiosins conjugated with selenium nanoparticles in rats exposed to chronic unpredictable mild stress is mediated through antioxidative, anti-inflammatory, anti-apoptotic, and neuromodulatory activities. Int J Nanomedicine2021; 16: 8447–8464.
35.
WeiDChenTYanM, et al.Synthesis, characterization, antioxidant activity and neuroprotective effects of selenium polysaccharide from Radix hedysari. Carbohydr Polym2015; 125: 161–168.
36.
ReuszA. Changes of ultraviolet absorption spectrum of rutin solutions due to sterilization. Klin Wochenschr1953; 31: 709–710.
37.
SaleemiMAAlallamBYongYK, et al.Synthesis of zinc oxide nanoparticles with bioflavonoid rutin: characterisation, antioxidant and antimicrobial activities and in vivo cytotoxic effects on artemia nauplii. Antioxidants (Basel)2022; 11(10): 1853.
38.
LiuJZhangSZhaoX, et al.Molecular simulation and experimental study on the inclusion of rutin with β-cyclodextrin and its derivative. J Mol Struct2022; 1254: 132359.
39.
LiuPXZhangTChenQ, et al.Biomimetic dendrimer-peptide conjugates for early multi-target therapy of Alzheimer’s disease by inflammatory microenvironment modulation. Adv Mater2021; 33(26): e2100746.
40.
SunJWeiCLiuY, et al.Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer’s disease. Biomaterials2019; 197: 417–431.
41.
ParkMWChaHWKimJ, et al.NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer’s diseases. Redox Biol2021; 41: 101947.
42.
MoultonMJBarishSRalhanI, et al.Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer’s disease-associated genes. Proc Natl Acad Sci U S A2021; 118(52): e2112095118.
43.
BaiRGuoJYeXY, et al.Oxidative stress: the core pathogenesis and mechanism of Alzheimer’s disease. Ageing Res Rev2022; 77: 101619.
44.
PiccialliITedeschiVCaputoL, et al.The antioxidant activity of limonene counteracts neurotoxicity triggered by Aβ1-42 oligomers in primary cortical neurons. Antioxidants (Basel)2021; 10(6): 937.
45.
LeeJSongKHuhE, et al.Neuroprotection against 6-OHDA toxicity in PC12 cells and mice through the Nrf2 pathway by a sesquiterpenoid from Tussilago farfara. Redox Biol2018; 18: 6–15.
46.
YuXLLiYNZhangH, et al.Rutin inhibits amylin-induced neurocytotoxicity and oxidative stress. Food Funct2015; 6(10): 3296–3306.
47.
AlvarinoRAlonsoELacretR, et al.Caniferolide A, a macrolide from streptomyces caniferus, attenuates neuroinflammation, oxidative stress, amyloid-beta, and tau pathology in vitro. Mol Pharm2019; 16(4): 1456–1466.
48.
LiLXuSLiuL, et al.Multifunctional compound AD-35 improves cognitive impairment and attenuates the production of TNF-α and IL-1β in an Aβ25-35-induced rat model of Alzheimer’s disease. J Alzheimers Dis2017; 56(4): 1403–1417.
49.
ChaoJLiPChaoL. Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress. Biol Chem2017; 398(12): 1309–1317.
50.
TortosaALopezEFerrerI. Bcl-2 and bax protein expression in Alzheimer’s disease. Acta Neuropathol1998; 95(4): 407–412.
51.
WangYMiaoYMirAZ, et al.Inhibition of beta-amyloid-induced neurotoxicity by pinocembrin through Nrf2/Ho-1 pathway in Sh-Sy5y cells. J Neurol Sci2016; 368: 223–230.
